Adaptive Implantable Canisters for Personalized Cellular and Biotherapeutic Agent Delivery

A next-generation, implantable canister system that dynamically adapts to in-vivo conditions, optimizing the delivery of cellular and biotherapeutic agents for personalized tissue repair and regeneration.

The original patent disclosed a metallic, nanoporous device for encapsulating cellular and biotherapeutic agents. However, this device had limitations in terms of its static porosity and inability to respond to changing in-vivo conditions. The new inventive concept addresses these limitations by introducing self-sustaining, adaptive canisters that dynamically adjust their porosity and release profiles in response to local tissue conditions, thereby optimizing therapeutic outcomes.

The new inventive concept comprises a system of implantable canisters with nanoscale, bicontinuous morphology that dynamically adjusts its porosity in response to local tissue conditions. This adaptation enables the canisters to optimize the diffusion of therapeutic factors, promoting tissue regeneration and repair. The canisters can be designed to selectively release therapeutic metabolites in response to changes in local oxygen levels, further enhancing their therapeutic potential. Additionally, the canisters can be interconnected to form a modular device, allowing for the simultaneous delivery of multiple, distinct biotherapeutic agents. The system can also integrate living cells with nanoporous, metallic surfaces, enabling the regeneration of damaged tissue through a self-healing mechanism.

The new claims introduce a paradigm shift in implantable canister technology by incorporating adaptive, dynamic porosity and real-time, in-vivo feedback. This enables the canisters to optimize therapeutic outcomes in a way that was not possible with the original patent's static design. The novelty lies in the canisters' ability to adapt to changing in-vivo conditions, making them more effective and personalized.

Alternative embodiments of the inventive concept could include canisters with different nanoscale morphologies, such as hierarchical or fractal structures, to further optimize their adaptive properties. The canisters could also be designed to respond to different in-vivo cues, such as pH or temperature changes, to enhance their therapeutic potential. Additionally, the system could be integrated with external sensors or monitoring devices to provide real-time feedback and further optimize therapeutic outcomes.

The new inventive concept has significant commercial potential in the fields of regenerative medicine, tissue engineering, and personalized healthcare. The adaptive canister system could be used to treat a wide range of degenerative diseases, such as osteoarthritis, diabetes, and cardiovascular disease. The market for such a system is substantial, with potential applications in both human and veterinary medicine.